Author(s)

Qiuyu Wang, Haihua Zheng

Corresponding Author

Qiuyu Wang

ABSTRACT

Objective: To analyze the therapeutic effect of mannitol on ophthalmic diseases. Method: 87 patients with ophthalmic diseases hospitalized from January 2020 to January 2022 were selected. 44 cases in group A were treated with mannitol and 43 cases in group B were treated with routine treatment. Results: The total effective rate of group A was significantly higher than that of group B (P < 0.05). There was no difference in intraocular pressure before treatment (P > 0.05). After 2 weeks of treatment, the intraocular pressure in group A was lower than that in group B (P < 0.05). The adverse reaction rate of group A was lower than that of group B, and the quality of life score of patients after 2 weeks of treatment was higher than that of group B (P < 0.05). Conclusion: Mannitol treatment for patients with ophthalmic diseases can restore intraocular pressure, reduce adverse drug reactions, and improve the quality of life.

KEYWORDS

Mannitol, Ophthalmic diseases, Intraocular pressure level, Adverse reactions, Quality of life